DK0692974T4 - Multikomponent clostridiumvacciner hvor saponin anvendes som adjuvans - Google Patents

Multikomponent clostridiumvacciner hvor saponin anvendes som adjuvans

Info

Publication number
DK0692974T4
DK0692974T4 DK94912333T DK94912333T DK0692974T4 DK 0692974 T4 DK0692974 T4 DK 0692974T4 DK 94912333 T DK94912333 T DK 94912333T DK 94912333 T DK94912333 T DK 94912333T DK 0692974 T4 DK0692974 T4 DK 0692974T4
Authority
DK
Denmark
Prior art keywords
vaccines
saponin
multicomponent
clostridium
adjuvant
Prior art date
Application number
DK94912333T
Other languages
English (en)
Other versions
DK0692974T3 (da
Inventor
David S Roberts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21899896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0692974(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of DK0692974T3 publication Critical patent/DK0692974T3/da
Application granted granted Critical
Publication of DK0692974T4 publication Critical patent/DK0692974T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/842—Clostridium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK94912333T 1993-03-29 1994-03-29 Multikomponent clostridiumvacciner hvor saponin anvendes som adjuvans DK0692974T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3842893A 1993-03-29 1993-03-29
PCT/US1994/003395 WO1994022476A1 (en) 1993-03-29 1994-03-29 Multicomponent clostridial vaccines using saponin adjuvants

Publications (2)

Publication Number Publication Date
DK0692974T3 DK0692974T3 (da) 2003-09-01
DK0692974T4 true DK0692974T4 (da) 2007-10-01

Family

ID=21899896

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94912333T DK0692974T4 (da) 1993-03-29 1994-03-29 Multikomponent clostridiumvacciner hvor saponin anvendes som adjuvans

Country Status (11)

Country Link
US (2) US6083512A (da)
EP (1) EP0692974B2 (da)
JP (1) JP4129544B2 (da)
AT (1) ATE240117T1 (da)
AU (1) AU689772B2 (da)
CA (1) CA2158651C (da)
DE (1) DE69432665T3 (da)
DK (1) DK0692974T4 (da)
ES (1) ES2199227T5 (da)
PT (1) PT692974E (da)
WO (1) WO1994022476A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743430B1 (en) * 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
KR0184779B1 (ko) * 1995-04-13 1999-04-01 성재갑 퀼라야 사포나리아 몰리나로부터 분리정제된 사포닌 변이체, 이의 분리정제 방법 및 이를 함유하는 백신 제형
GB9620795D0 (en) * 1996-10-05 1996-11-20 Smithkline Beecham Plc Vaccines
ATE273712T1 (de) * 1996-02-02 2004-09-15 Zentaris Gmbh Methode zur inaktivierung von proteinen der ras- unterfamilie und verbindungen dafuer
FR2768747B1 (fr) * 1997-09-19 2000-12-01 Pasteur Institut Acides nucleiques, cellules recombinantes, et procede de preparation de compositions immunogenes
US6524592B2 (en) * 1997-10-17 2003-02-25 American Home Products Corporation Veterinary vaccines
US6905712B2 (en) * 1999-12-08 2005-06-14 Statens Veterinarmedicinska Anstalt Vaccine adjuvants comprising ginseng plant extract and added aluminum salt
DE10035156A1 (de) * 2000-07-19 2002-02-07 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Proteinkomplex als Vehikel für oral verfügbare Protein-Arzneimittel
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
US6974577B2 (en) * 2001-02-04 2005-12-13 Novartris Ag Inactivated bovine scours vaccines, processes and method of preventing bovine scours
US7220421B2 (en) * 2001-06-19 2007-05-22 The Regents Of The University Of California Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of Moraxella bovis infections
MY149604A (en) * 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine
BR112013027229B1 (pt) 2011-04-22 2020-10-27 Wyeth Llc polipeptídeo imunogênico isolado e seu uso, composição imunogênica e seu uso, célula recombinante ou progênie da mesma, e método de produção de uma toxina de clostridium difficile mutante
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
CN106177935A (zh) * 2016-08-19 2016-12-07 齐鲁动物保健品有限公司 一种反刍动物梭菌病四联灭活疫苗及其制备方法
CN110244042B (zh) * 2019-07-24 2020-08-14 山东农业大学 羊腐败梭菌的间接elisa检测试剂盒

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883425A (en) * 1973-12-10 1975-05-13 Wadley Res Inst & Blood Bank Detoxification of saponins
SU627610A1 (ru) * 1977-09-30 1980-02-05 Zemlyakova V P Препарат землаково в.п. против клюстридиозов животных и птиц
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5084269A (en) * 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
IT1198234B (it) * 1986-12-23 1988-12-21 Zambon Spa Processo stereoconvergente per la preparazione di acidi carbossilici otticamente attivi
US5583112A (en) * 1987-05-29 1996-12-10 Cambridge Biotech Corporation Saponin-antigen conjugates and the use thereof
US5043158A (en) * 1987-08-21 1991-08-27 Chembiomed, Ltd. Immunogenic compositions containing ordered carriers
NZ230747A (en) * 1988-09-30 1992-05-26 Bror Morein Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
AU2297888A (en) * 1988-09-30 1990-04-05 Lovgren, Karin A complex comprising adjuvants and lipids
US5646247A (en) * 1989-04-05 1997-07-08 New York University Merozoite antigens localized at the apical end of the parasite
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
US5736139A (en) * 1989-10-31 1998-04-07 Ochidian Pharmaceuticals, Inc. Treatment of Clostridium difficile induced disease
US5270202A (en) * 1989-11-03 1993-12-14 Syamal Raychaudhuri Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
NZ242065A (en) * 1991-03-26 1996-06-25 Csl Ltd Delayed release implant having a degradable or rupturable polymeric coating
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome

Also Published As

Publication number Publication date
US20010002256A1 (en) 2001-05-31
DK0692974T3 (da) 2003-09-01
PT692974E (pt) 2003-09-30
US6083512A (en) 2000-07-04
AU689772B2 (en) 1998-04-09
ES2199227T3 (es) 2004-02-16
EP0692974B1 (en) 2003-05-14
ATE240117T1 (de) 2003-05-15
ES2199227T5 (es) 2007-12-01
JPH08510206A (ja) 1996-10-29
EP0692974A4 (en) 1999-04-07
DE69432665T3 (de) 2007-12-06
CA2158651C (en) 2009-09-01
JP4129544B2 (ja) 2008-08-06
DE69432665T2 (de) 2003-11-27
WO1994022476A1 (en) 1994-10-13
CA2158651A1 (en) 1994-10-13
DE69432665D1 (de) 2003-06-18
EP0692974B2 (en) 2007-05-30
AU6493994A (en) 1994-10-24
EP0692974A1 (en) 1996-01-24

Similar Documents

Publication Publication Date Title
DK0692974T4 (da) Multikomponent clostridiumvacciner hvor saponin anvendes som adjuvans
FI953442A (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
DK1149589T3 (da) Proteinadjuvanser
IE44190L (en) Glucosamine derivatives
DK0777490T3 (da) Mutant-enterotoxin, som er effektivt som et ikke-toksisk oralt adjuvans
EP1170016A3 (en) Urease-based vaccine against helicobacter infection
GB9207731D0 (en) Improvements in or relating to vaccines
AU9094191A (en) Recombinant avirulent salmonella antifertility vaccines
ES8802209A1 (es) Procedimiento de acondicionar preparados de vacunas inyectables a animales.
EP0979080A4 (en) METHOD FOR MODULATING THE IMMUNE REACTION IN AN INFECTIVE MAMMALIAN BY THE TRANSMUCOSAL ENTERING A MODULATING AGENT
ATE182270T1 (de) Mukosale verabreichung von pneumokokken-antigenen
IE38555L (en) Colibacillosis vaccines.
CA2128247A1 (en) Vaccines based on streptokinase
HK1025220A1 (en) Novel saponin compositions and uses thereof
GB1303976A (da)
ES515472A0 (es) Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.
WATANABE et al. On the rooting of cuttings of 22 species in Genus Pinus
FR2342073A1 (fr) Nouveau vaccin antivariolique sous forme de pate et son dispositif d'application
RU96119157A (ru) Ассоциированная вакцина "нековак" против некробактериоза крупного рогатого скота
NO931821L (no) Hepatitt b vaksinepreparat som omfatter et gallesyresalt
AU249643B2 (en) 1, 1-dicyclohexyl-2-(2'piperidyl) ethylene and its preparation
AU462761A (en) 1, 1-dicyclohexyl-2-(2'piperidyl) ethylene and its preparation